Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Braze (BRZE) Stock Forecast & Price Target

$31.20
+0.27 (+0.87%)
(As of 10/22/2024 ET)

Braze - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
19

Based on 19 Wall Street analysts who have issued ratings for Braze in the last 12 months, the stock has a consensus rating of "Buy." Out of the 19 analysts, 19 have given a buy rating for BRZE.

Consensus Price Target

$57.33
83.76% Upside
According to the 19 analysts' twelve-month price targets for Braze, the average price target is $57.33. The highest price target for BRZE is $75.00, while the lowest price target for BRZE is $37.00. The average price target represents a forecasted upside of 83.76% from the current price of $31.20.

BRZE Analyst Ratings Over Time

TypeCurrent Forecast
10/24/23 to 10/23/24
1 Month Ago
9/24/23 to 9/23/24
3 Months Ago
7/26/23 to 7/25/24
1 Year Ago
10/24/22 to 10/24/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
19 Buy rating(s)
17 Buy rating(s)
17 Buy rating(s)
15 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$57.33$60.50$61.13$53.74
Forecasted Upside83.76% Upside74.73% Upside46.90% Upside21.96% Upside
Consensus Rating
Buy
Buy
Buy
Moderate Buy

BRZE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BRZE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Braze Stock vs. The Competition

TypeBrazeBusiness Services CompaniesS&P 500
Consensus Rating Score
3.00
2.67
2.50
Consensus RatingBuyModerate BuyHold
Predicted Upside83.76% Upside271.08% Upside7.90% Upside
News Sentiment Rating
Positive News

See Recent BRZE News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/22/2024Stifel Nicolaus
4 of 5 stars
 Initiated CoverageBuy$37.00+19.62%
10/10/2024Piper Sandler
2 of 5 stars
 Lower TargetOverweight ➝ Overweight$51.00 ➝ $40.00+33.29%
9/25/2024UBS Group
4 of 5 stars
 Lower TargetBuy ➝ Buy$56.00 ➝ $51.00+55.11%
9/24/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$52.00 ➝ $45.00+39.45%
9/24/2024DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$65.00 ➝ $55.00+70.44%
9/24/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Outperform ➝ Market Outperform$68.00 ➝ $68.00+109.23%
Watch this before it gets removed (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

9/24/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$60.00 ➝ $51.00+47.29%
9/24/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$75.00 ➝ $75.00+116.61%
9/24/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$70.00 ➝ $70.00+102.17%
8/26/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$80.00 ➝ $70.00+51.48%
7/10/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Altmann
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform ➝ Sector Outperform$48.00 ➝ $56.00+47.68%
6/7/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$52.00 ➝ $58.00+57.48%
6/7/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$65.00 ➝ $55.00+41.72%
6/7/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$50.00 ➝ $53.00+44.10%
5/31/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$68.00 ➝ $62.00+65.29%
4/29/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$75.00 ➝ $65.00+50.46%
3/28/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$60.00 ➝ $58.00+24.68%
3/28/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform
12/7/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$55.00 ➝ $63.00+17.23%
12/14/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$47.00 ➝ $44.00+52.25%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 05:23 AM ET.


BRZE Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Braze is $57.33, with a high forecast of $75.00 and a low forecast of $37.00.

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Braze in the last year. There are currently 19 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BRZE shares.

According to analysts, Braze's stock has a predicted upside of 83.76% based on their 12-month stock forecasts.

Braze has been rated by research analysts at Barclays, DA Davidson, JMP Securities, Loop Capital, Needham & Company LLC, Oppenheimer, Piper Sandler, Stifel Nicolaus, TD Cowen, and UBS Group in the past 90 days.

Analysts like Braze more than other "business services" companies. The consensus rating for Braze is Buy while the average consensus rating for "business services" companies is Moderate Buy. Learn more on how BRZE compares to other companies.


This page (NASDAQ:BRZE) was last updated on 10/23/2024 by MarketBeat.com Staff
From Our Partners